OliX Pharmaceuticals

OliX Pharmaceuticals (previously known as BMT) is a biotechnology company. It builds its own proprietary RNA interference (RNAi) technology regulating the expression of disease-causing genes. The company develops RNAi therapeutics for dermal, ophthalmic and pulmonary diseases, which can be locally administered.